Clinical Trials(3103 results)View more
Drugs(1245 results)View more
Companies(27 results)View more
News(875 results)View more
RNatives Secures €1.4M Seed Extension to Advance RNA-Based Gene Regulation Platform
5/27/2025
RNatives raised €1.4 million in additional seed funding led by Nordic Science Investments, bringing total seed funding to €2.8 million to accelerate its RNA-based gene regulating platform.
RNA Editing Shows Promise in Treating Genetic Conditions Where DNA Editing Falls Short
11/7/2024
Wave Life Sciences pioneered clinical RNA editing, treating alpha-1 antitrypsin deficiency (AATD) by correcting mRNA mutations, offering a novel therapeutic approach.
Next-Generation RNA Technologies Promise Longer-Lasting Therapeutics Beyond mRNA
8/22/2022
Biotech companies are developing novel RNA technologies, including circular RNA and transfer RNA, to overcome the rapid degradation limitations of current mRNA therapeutics.
Biostate AI Secures $12M Series A to Revolutionize RNA Sequencing and Molecular Diagnostics
5/20/2025
Biostate AI has raised $12 million in Series A funding led by Accel to develop affordable RNA sequencing technology and AI-powered diagnostic models.